Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Click here to sign in with or

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
12/08/2021

Archive: 12/08/2021

American Academy of Pediatrics: Consider palivizumab for atypical interseason respiratory syncytial virus

(HealthDay)—Palivizumab, which is usually considered for use to decrease the risk for hospitalization in selected infants at increased risk for severe respiratory syncytial virus (RSV) disease during the typical season, ...

Aug 12, 2021

0

5

CDC's 'honor system' mask guidance threatened vulnerable communities

The Centers for Disease Control and Prevention (CDC) may have increased the threat of COVID-19 infection in the Black community and among some other racial and ethnic minority groups when the agency updated its mask guidance ...

Aug 12, 2021

2

15

Study shows short naps don't relieve sleep deprivation

A nap during the day won't restore a sleepless night, says the latest study from Michigan State University's Sleep and Learning Lab.

Aug 12, 2021

0

89

In transplant recipients, COVID-19 vaccines reduce infection and mortality risks

Vaccination against SARS-CoV-2 substantially lowers the risks of "breakthrough" infections and death due to COVID-19 in adult organ transplant recipients, according to a pair of research letters in Transplantation, the official ...

Aug 12, 2021

0

400

Moderna vaccine may shield more against breakthrough infections than Pfizer: study

People fully vaccinated with the Moderna COVID-19 vaccine appear to have a lower risk of a "breakthrough" infection caused by the Delta variant than those who received the Pfizer vaccine, a new, preliminary report suggests.

Aug 12, 2021

0

1103

Cabotegravir bests TDF-FTC for HIV prevention in those at risk

(HealthDay)—For men who have sex with men (MSM) and transgender women, long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) is superior to tenofovir disoproxil fumarate-emtricitabine ...

Aug 12, 2021

0

143

From blood to brain: Delivering nucleic acid therapy to the central nervous system

Researchers from Tokyo Medical and Dental University (TMDU), Takeda Pharmaceutical Co., Ltd. and Ionis Pharmaceuticals, USA, show that heteroduplex oligonucleotide drugs conjugated with cholesterol cross the blood–brain ...

Aug 12, 2021

0

288

Potential new therapeutic approach for chronic inflammatory bowel diseases

Why people suffer from chronic inflammatory bowel diseases (IBD) such as ulcerative colitis is only partially understood. However, it is known that the bacteria of the intestinal flora and dysfunction in the immune system ...

Aug 12, 2021

0

613

Phone app captures measures of functional impairment in multiple sclerosis

(HealthDay)—For persons with multiple sclerosis (MS), a smartphone device captures reliable and clinically relevant measures of functional impairment, according to a study published online July 14 in the Multiple Sclerosis ...

Aug 12, 2021

0

93

mRNA-1273 SARS-CoV-2 vaccine seems safe for adolescents

(HealthDay)—The results of an interim analysis suggest that two doses of the Moderna mRNA-1273 vaccine safely induce protective levels of antibodies to SARS-CoV-2 among adolescents, according to a study published online ...

Aug 12, 2021

1

2

page 3 from 11

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2025 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us